|
|
Title | Creator | Relation Is Part Of |
51 |
|
Double-Blind Cross-Over Trial Of Gabapentin And Memantine For Treatment Of Acquired Nystagmus | M. J. Thurtell; A. C. Joshi; A. C. Leone; R. L. Tomsak; G. S. Kosmorsky; J. S. Stahl; R. J. Leigh | NANOS 2010: Scientific Platform Presentations |
52 |
|
The Effect of 4-aminopyridine on the Velocity Versional Dysconjugacy Index (VDI), an Objective Ocular Motor Metric of Dysconjugacy Associated with INO in MS Patients, During High Precision Escalation in Core Body Temperature | Teresa Frohman; Davis Scott; Beh Josh; Conger Amy; Conger Darrell; Remington Gina; Frohman Ashley; Frohman Elliot | NANOS 2014: Poster Presentations |
53 |
|
Emerging Therapies of Multiple Sclerosis | Jeffrey Bennett, MD, PhD | NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art |
54 |
|
European Perspective - It Could Be MS | Axel Petzold, MD, PhD, FRCP, FRCPath, FRCOphth | NANOS Annual Meeting 2023: State of the Art - Global Perspectives |
55 |
|
Existing Therapies for Treatment of MS | Ari J. Green, MD | NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art |
56 |
|
Exploring the Oculomotor Effects of Sustained-Release Fampridine in Multiple Sclerosis Patients with Gait Impairment. (.pdf) | Cristina Duque; Jose Coelho; Joana Marcal; Isabel Ribeiro; Alda Melo; Carla Nunes; Carmo Macario; Sonia Batista; Livia Abreu; Joao Lemos | NANOS Annual Meeting 2016: Poster Presentations |
57 |
|
Exploring the Temporal Evolution of Structural and Functional Changes after Acute Optic Neuritis | Fiona Costello; Irene Pan; Jodie Burton; Jessie Trufyn; William Hodge | NANOS 2013: Platform Presentations (Session I) |
58 |
|
Extra-Axonal Ocular Damage Quantification by Multifocal Electroretinography in Chronic Progressive Multiple Sclerosis | Arielle R. Spitze; Nagham Al-Zubidi; Sushma Yalamanchili; Fiona Costello; Andrew G. Lee | NANOS 2013: Poster Presentations |
59 |
|
Factors in Optic Nerve Conduction - VEP Analysis | John B. Selhorst, MD | NANOS 1983: Various Subjects Symposium |
60 |
|
Familial Multiple Sclerosis Presenting With Familial Intracranial Hypertension | Benjamin Osborne | NANOS 2010: Poster Presentations |
61 |
|
The Final 15-Year Follow-up Report on the Neurological Outcome of the Optic Neuritis Treatment Trial | M. Tariq Bhatti | NANOS 2008: Platform Session I |
62 |
|
Five- to Seven-Year Longitudinal Data for Vision and OCT Retinal Nerve Fiber Layer (RNFL) Thickness in MS | Stephen J. Moster; Lauren Talman; James Wilson; Kristin Galetta; Reiko Sakai; Steven L. Galetta; Elliot Frohman; Peter Calabresi; Laura J. Balcer | NANOS 2012: Scientific Platform Presentations (Session I) |
63 |
|
Functional Connectivity in Patients with Clinically Isolated Optic Neuritis | Gregory P. Van Stavern; Beau Ances; Gregory Wu; Mae Gordon; Julie Huecker | NANOS 2013: Platform Presentations (Session II) |
64 |
|
Functional Connectivity in Patients with Clinically Isolated Optic Neuritis | Gregory P. Van Stavern; Beau Ances; Gregory Wu; Mae Gordon; Julie Huecker | NANOS 2013: Platform Presentations (Session II) |
65 |
|
Further Characterization of the Melanopsin-Mediated Pupillary Light Reflex in Multiple Sclerosis | Marlen Lucero; Ethan Meltzer; Peter Sguigna; Mirna Lucero; Amy Conger; Darrel Conger; Victoria Stokes; Josh Beh; Rob Rennaker; Laura Balcer; Peter Calabresi; Teresa Frohman; Randy Kardon; Elliot Frohman | NANOS 2014: Poster Presentations |
66 |
|
Gender and retinal nerve fiber layer thickness in patients with non-acute optic neuritis | Jessie Trufyn; Fiona Costello | NANOS 2012: Poster Presentations |
67 |
|
Gene Expression Patterns of Peripheral Blood-Cells Subpopulations in Acute Optic Neuritis | Ruth Huna-Baron; Anna Feldman; Michael Gurevich; Anat Achiron | NANOS 2009: Scientific Platform Presentations (Session I) |
68 |
|
Historical Perspective on the Diagnosis and Treatment of Optic Neuritis | Nicholas J. Volpe | NANOS 2001: Optic Neuritis and Multiple Sclerosis Symposium |
69 |
|
Homonymous Hemianopia as a Clinically Isolated Syndrome Heralding Multiple Sclerosis | Archana Abhayambika; Arun N. E. Sundaram; James A. Sharpe | NANOS 2010: Poster Presentations |
70 |
|
How Do Retinal Nerve Fiber Layer Axonal Loss and Visual Dysfunction Affect Quality of Life in MS? | A. Daniels; J. Fisher; D. Jacobs; C. Markowitz; S. Galetta; N. Volpe; M. L. Nano-Schiavi; M. Baier; G. Cutter; H. Winslow; P. Calabresi; M. Maguire; L. Balcer | NANOS 2006: Poster Presentations |
71 |
|
Humoral Immunity in Optic Neuritis and Multiple Sclerosis | Jeffrey L. Bennett, MD | NANOS 2007: Immunological Diseases in Neuro-Ophthalmology |
72 |
|
Idiopathic Chiasmal Neuritis | Aki Kawasaki; Valerie Purvin | NANOS 2007: Poster Presentations |
73 |
|
Immunoglobin Heavy-Chain Repertoire Bias and the Risk of Demyelinating Disease in Isolated Optic Neuritis | J. Bennett; A. Ritchie; K. Haubold; D. Gilden; G. Owens | NANOS 2006: Scientific Platform Presentations (Session I) |
74 |
|
Immunoglobulin Therapy | Shelley A. Cross, MD | NANOS 1995: Visual System Injury Symposium |
75 |
|
Immunology of Multiple Sclerosis | Barry G. W. Amason | NANOS 1996: Multiple Sclerosis Symposium |